Search research articles
Contact Us
Filters
Showing results (51-60 of 430) with videos related to
Page
of 43
Sort By:
Current Opinion in Neurology
|
July 19, 2003
Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials?
Gillian P Bates, Emma Hockly
EMBO Reports
|
October 2, 2004
Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series
Christian Landles, Gillian P Bates
Molecular Biotechnology
|
January 31, 2006
Mouse models of triplet repeat diseases
Gillian P Bates, Roman Gonitel
Nucleic Acids Research
|
January 26, 1987
RFLP for pHM20 (D2S12), an anonymous DNA sequence localised to 2p23-2pter
G P Bates, R Williamson
AUAA Journal : Official Journal of the American Urological Association Allied
|
July 1, 1987
The cranberry juice cure: fact or fiction?
S M Howe, P Bates
BMC Medical Genomics
|
November 1, 2014
A common gene expression signature in Huntington's disease patient brain regions
Andreas Neueder, Gillian P Bates
Journal of Virology
|
April 3, 1998
Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines
R J Wool-Lewis, P Bates
Journal of Virology
|
May 1, 1997
Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection
L Rong, A Edinger, P Bates
Journal of Virology
|
January 9, 1999
Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function
R J Wool-Lewis, P Bates
Journal of Virology
|
March 12, 1999
Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits
R Damico, L Rong, P Bates
Page
of 43
Search research articles
Search
Showing results (51-60 of 430) with videos related to
Sort By:
Page
of 43
Current Opinion in Neurology
|
July 19, 2003
Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials?
Gillian P Bates, Emma Hockly
EMBO Reports
|
October 2, 2004
Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series
Christian Landles, Gillian P Bates
Molecular Biotechnology
|
January 31, 2006
Mouse models of triplet repeat diseases
Gillian P Bates, Roman Gonitel
Nucleic Acids Research
|
January 26, 1987
RFLP for pHM20 (D2S12), an anonymous DNA sequence localised to 2p23-2pter
G P Bates, R Williamson
AUAA Journal : Official Journal of the American Urological Association Allied
|
July 1, 1987
The cranberry juice cure: fact or fiction?
S M Howe, P Bates
BMC Medical Genomics
|
November 1, 2014
A common gene expression signature in Huntington's disease patient brain regions
Andreas Neueder, Gillian P Bates
Journal of Virology
|
April 3, 1998
Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines
R J Wool-Lewis, P Bates
Journal of Virology
|
May 1, 1997
Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection
L Rong, A Edinger, P Bates
Journal of Virology
|
January 9, 1999
Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function
R J Wool-Lewis, P Bates
Journal of Virology
|
March 12, 1999
Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits
R Damico, L Rong, P Bates
Page
of 43